As part of the TÜBİTAK 1004 Center of Excellence Support Program, under the "High Technology Platforms Call," the project titled "Development of an Exosome-Based Therapy Protocol for the Treatment of Patients with Meniscus Injury" (TÜBİTAK 1004, 20AG031) is one of the three projects led by the research program of the ESOGÜ-ESTEM Stem Cell Center within the scope of the "Regenerative and Restorative Medicine Research and Applications" (18AG006) project. Among our external stakeholders, STEMBIO Cord Blood, Stem Cell, and Tissue Center, which operates as a stem cell and tissue production center under cGMP conditions with a Turkish Ministry of Health TİTCK activity certificate. On January 17, 2025, a training, meeting, and on-site visit titled "Cell and Cellular Therapy Product Manufacturing Standards" will be held under GMP conditions at the TÜBİTAK MARTEK campus in Gebze.